# Patient Report: SUBJ_001_PSEUDO

**Generated**: 2026-02-25T18:59:40.084618

## Prediction
- **Prediction Type**: binary_classification
- **Primary Output**: DEPRESSION
- **Probability / Root Confidence**: 92.0%
- **Confidence**: HIGH
- **Target Label Context**: DEPRESSION
- **Comparator Label Context**: HEALTHY

## Evaluation
- **Verdict**: SATISFACTORY
- **Checklist**: 8/8 passed

## Key Findings
1. **[CLINICAL_NOTES]** Persistent low mood, anhedonia, fatigue, early morning awakening, reduced appetite with 4-5kg weight loss, impaired concentration, social withdrawal over 7-8 months; moderate mood scale 17/27
2. **[BIOLOGICAL_ASSAY]** Neurotrophic factors reduced (z=-1.7; BDNF z=-2.0, 2nd percentile)
3. **[BIOLOGICAL_ASSAY]** Sphingolipids elevated (z=1.7); inflammation markers CRP z=1.7, HPA axis z=1.2
4. **[BRAIN_MRI]** Subcortical volumes reduced (z=-1.4; left hippocampus z=-2.0, 2nd percentile)
5. **[BRAIN_MRI]** Resting-state functional connectivity elevated (z=1.3; DMN mpfc-pcc z=2.5)

## Clinical Summary
This 45-year-old female exhibits a classic melancholic depression phenotype with 7-8 months of persistent low mood, anhedonia, neurovegetative symptoms (early awakening, weight loss, fatigue), cognitive impairment, and functional decline, corroborated by multimodal biomarkers including reduced BDNF/hippocampal volume (z=-2.0), elevated inflammation/HPA/sphingolipids (z=1.7), limbic hyperconnectivity (z=2.5), genetic risk, stress/sleep dysregulation, and mild executive slowing. Prior episode and family history further support recurrent MDD over healthy control, warranting intervention.

## Reasoning Chain
1. Step 1: Prioritize non_numerical_data showing explicit DSM-aligned symptoms (low mood, anhedonia, insomnia, weight loss, concentration issues) with functional impact and moderate rating scales, overriding biomarkers as supportive.
2. Step 2: Confirm multimodal convergence from FeatureSynthesizer/ClinicalRelevanceRanker/DifferentialDiagnosis (85% MDD likelihood, strong case/control discrimination via HPA/limbic/inflammation clusters).
3. Step 3: Quantify key z-scores (>1.5 in 6+ depression-relevant leaves across 5 domains) per hierarchy; no isolated deficits.
4. Step 4: Calibrate probability high (0.92) given prevalence-aware elevation, convergent evidence minimizing FP risk; HIGH confidence from data quality/consistency.

## Execution Details
- **Iterations**: 1
- **Selected Iteration**: 1
- **Selection Reason**: Satisfactory verdict available; chose strongest satisfactory attempt (iteration 1).
- **Tokens Used**: 106,087
- **Domains Processed**: BIOLOGICAL_ASSAY, BRAIN_MRI, COGNITION, LIFESTYLE_ENVIRONMENT, DEMOGRAPHICS